BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 21664652)

  • 1. Effect of renal function on urinary mineral excretion and stone composition.
    Kadlec AO; Greco KA; Fridirici ZC; Gerber D; Turk TM
    Urology; 2011 Oct; 78(4):744-7. PubMed ID: 21664652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Impaired Renal Function With Changes in Urinary Mineral Excretion and Stone Composition.
    Patel PM; Kandabarow AM; Druck A; Hart S; Blackwell RH; Kadlec A; Farooq A; Turk TMT; Baldea KG
    Urology; 2020 Jul; 141():45-49. PubMed ID: 32294484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and urinary stone composition: what factors matter most?
    Kadlec AO; Greco K; Fridirici ZC; Hart ST; Vellos T; Turk TM
    Urology; 2012 Oct; 80(4):805-10. PubMed ID: 22795374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using 24-hour urinalysis to predict stone type.
    Moreira DM; Friedlander JI; Hartman C; Elsamra SE; Smith AD; Okeke Z
    J Urol; 2013 Dec; 190(6):2106-11. PubMed ID: 23764079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in 24-hour urine composition between apatite and brushite stone formers.
    Moreira DM; Friedlander JI; Hartman C; Elsamra SE; Smith AD; Okeke Z
    Urology; 2013 Oct; 82(4):768-72. PubMed ID: 23791217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.
    Cameron MA; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
    J Am Soc Nephrol; 2006 May; 17(5):1422-8. PubMed ID: 16597681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal tubular function in children with hypercalciuria].
    Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
    Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of estimated glomerular filtration rate with 24-h urinalysis and stone composition.
    Moreira DM; Friedlander JI; Hartman C; Gershman B; Smith AD; Okeke Z
    Urolithiasis; 2016 Aug; 44(4):319-25. PubMed ID: 26573808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus.
    Hartman C; Friedlander JI; Moreira DM; Elsamra SE; Smith AD; Okeke Z
    BJU Int; 2015 Apr; 115(4):619-24. PubMed ID: 24823472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of factors involved in calcium stone formation.
    Abraham PA; Smith CL
    Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemia and kidney stone risk.
    Torricelli FC; De SK; Gebreselassie S; Li I; Sarkissian C; Monga M
    J Urol; 2014 Mar; 191(3):667-72. PubMed ID: 24055417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sodium excretion in children with lithogenic disorders].
    Kovacević L; Kovacević S; Smoljanić Z; Peco-Antić A; Kostić N; Gajić M; Kovacević N; Jovanović O
    Srp Arh Celok Lek; 1998; 126(9-10):321-6. PubMed ID: 9863402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the urinary calcium in the growth of calcium stone.
    Murayama T; Sakai N; Takano T; Yamada T
    Hinyokika Kiyo; 2004 Jul; 50(7):451-5. PubMed ID: 15334887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis.
    Sakhaee K; Adams-Huet B; Moe OW; Pak CY
    Kidney Int; 2002 Sep; 62(3):971-9. PubMed ID: 12164880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.